Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: A European and USA International collaborative analysis Academic Article uri icon

Overview

MeSH Major

  • Esophageal Neoplasms
  • Esophagogastric Junction
  • Neoplasm Metastasis
  • Stomach Neoplasms

abstract

  • Approximately 20% of Western patients with metastatic gastric cancer are HER2 positive. Unlike breast cancer, HER2 positivity is not independently prognostic of patient outcome in metastatic gastric or GEJ.

publication date

  • October 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/annonc/mds104

PubMed ID

  • 22689179

Additional Document Info

start page

  • 2656

end page

  • 62

volume

  • 23

number

  • 10